{
    "Trade/Device Name(s)": [
        "3test Glucose Monitoring System",
        "3TM678G Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Neuero Engineering Inc.",
    "510(k) Number": "K050224",
    "Predicate Device Reference 510(k) Number(s)": [
        "K964630"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "July 2, 2005",
    "Summary Letter Received Date": "July 6, 2005",
    "Submission Date": "January 26, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "3test Glucose Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [
        "Capillary action",
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for 3test Glucose Monitoring System based on electrochemical biosensor for self and professional blood glucose monitoring",
    "Indications for Use Summary": "For measuring glucose in whole blood for self-monitoring by diabetics at home or professional use in clinical settings; not for use with neonates",
    "fda_folder": "Clinical Chemistry"
}